BioSpace News Archive

BioMidwest

Ionetix to provide Bayer with Therapeutic Radioisotope Actinium-225 (Ac-225)

Ionetix Corporation announced the signing of a supply agreement for the therapeutic radioisotope actinium-225 with Bayer.

November 15, 2023
·
2 min read
Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the 6th Annual Evercore ISI HealthCONx Conference Tuesday, November 28 at 1:45 pm EST (10:45 am PST/6:45 pm GMT) and will be hosting in-person meetings with the investment community at the conference.

November 15, 2023
·
1 min read
Business

Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results

Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, reported financial results for the three months ending September 30, 2023 and provided a business update.

November 15, 2023
·
9 min read
Business

Kite and Arcellx Announce Expansion in Strategic Partnership

Kite, a Gilead Company, and Arcellx, Inc., announced that the companies have expanded their existing collaboration, which was originally announced in December 2022.

November 15, 2023
·
11 min read
Pharm Country

Seneca Therapeutics Announces Publication of TEM8 Review Article “TEM8 in Oncogenesis” in Cells Journal

Seneca Therapeutics, Inc., announced the publication of “TEM8 in Oncogenesis” in Cells.

November 15, 2023
·
2 min read
Business

Oculis Reports Q3 2023 Financial Results and Provides Company Update

Oculis Holding AG (Nasdaq: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced third quarter financial results for the period ended September 30, 2023, and an overview of the Company’s progress.

November 15, 2023
·
15 min read
Business

Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer

Pharvaris today announced the appointment of Stefan Abele, Ph.D., as Chief Technical Operations Officer.

November 15, 2023
·
6 min read
Deals

NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications

NanoViricides, Inc. (NYSE American: NNVC ) reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2023 with the Securities and Exchange Commission (SEC) on Tuesday, November 14, 2023.

November 15, 2023
·
11 min read
NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing

NMD Pharma A/S today announces that it has raised €75 million (~$80 million) in a Series B financing.

November 15, 2023
·
3 min read
Business

Proxygen Announces Formation of Scientific Advisory Board

Proxygen, a leader in the discovery and development of molecular glue degraders, announced the formation of the company’s scientific advisory board.

November 15, 2023
·
7 min read